Use of combinatorial mutagenesis to select for multiply substituted human interleukin-3 variants with improved pharmacologic properties.
Klein BK, Olins PO, Bauer SC, Caparon MH, Easton AM, Braford SR, Abrams MA, Klover JA, Paik K, Thomas JW, Hood WF, Shieh JJ, Polazzi JO, Donnelly AM, Zeng DL, Welply JK, McKearn JP.
Klein BK, et al. Among authors: shieh jj.
Exp Hematol. 1999 Dec;27(12):1746-56. doi: 10.1016/s0301-472x(99)00118-6.
Exp Hematol. 1999.
PMID: 10641592
Free article.